Hillsdale Investment Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-60
| Closed | -$6K | – | 548 |
|
|
2016
Q4 | $6K | Hold |
60
| – | – | ﹤0.01% | 384 |
|
|
2016
Q3 | $7K | Hold |
60
| – | – | ﹤0.01% | 406 |
|
|
2016
Q2 | $9K | Sell |
60
-200
| -77% | -$30K | ﹤0.01% | 401 |
|
|
2016
Q1 | $38K | Sell |
260
-20
| -7% | -$2.92K | 0.01% | 342 |
|
|
2015
Q4 | $43K | Sell |
280
-2,300
| -89% | -$353K | 0.02% | 346 |
|
|
2015
Q3 | $369K | Sell |
2,580
-300
| -10% | -$42.9K | 0.12% | 154 |
|
|
2015
Q2 | $414K | Buy |
2,880
+200
| +7% | +$28.8K | 0.13% | 149 |
|
|
2015
Q1 | $378K | Buy |
2,680
+700
| +35% | +$98.7K | 0.1% | 185 |
|
|
2014
Q4 | $293K | Sell |
1,980
-200
| -9% | -$29.6K | 0.08% | 247 |
|
|
2014
Q3 | $335K | Sell |
2,180
-600
| -22% | -$92.2K | 0.11% | 155 |
|
|
2014
Q2 | $390K | Sell |
2,780
-300
| -10% | -$42.1K | 0.09% | 138 |
|
|
2014
Q1 | $342K | Sell |
3,080
-220
| -7% | -$24.4K | 0.1% | 148 |
|
|
2013
Q4 | $326K | Sell |
3,300
-600
| -15% | -$59.3K | 0.1% | 163 |
|
|
2013
Q3 | $296K | Buy |
+3,900
| New | +$296K | 0.09% | 200 |
|